Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Wassmann

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|June 15, 2019
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysisPaul M Haller, Patrick Sulzgruber, Christoph Kaufmann, et al.
Hypertension (Dallas, Tex. : 1979)|December 22, 2010
Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stressTalin Ebrahimian, Melissa Wei Li, Catherine A Lemarié, et al.
Journal of Comparative Effectiveness Research|March 22, 2022
Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in GermanyThomas Wilke, Burkhard Weisser, Hans-Georg Predel, et al.
Basic Research in Cardiology|April 13, 2011
Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutaseDerya Sivritas, Marc Ulrich Becher, Talin Ebrahimian, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 10, 2019
Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyIvana Hollan, Nicoletta Ronda, Patrick Dessein, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 13, 2019
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trialsHeinz Drexel, Giuseppe M C Rosano, Basil S Lewis, et al.
Basic Research in Cardiology|January 26, 2020
Murine sca1/flk1-positive cells are not endothelial progenitor cells, but B2 lymphocytesEva Steffen, Wolfgang Bernd Edziu Mayer von Wittgenstein, Marie Hennig, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2006
NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- miceMatthias Oelze, Ascan Warnholtz, Jörg Faulhaber, et al.
European Heart Journal|August 30, 2025
Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)Sigrid Sandner, Mario Gaudino, Stefan Agewall, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 30, 2025
Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)Sigrid Sandner, Mario Gaudino, Stefan Agewall, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
European Heart Journal. Cardiovascular Pharmacotherapy|June 15, 2019
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysisPaul M Haller, Patrick Sulzgruber, Christoph Kaufmann, et al.
Hypertension (Dallas, Tex. : 1979)|December 22, 2010
Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stressTalin Ebrahimian, Melissa Wei Li, Catherine A Lemarié, et al.
Journal of Comparative Effectiveness Research|March 22, 2022
Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in GermanyThomas Wilke, Burkhard Weisser, Hans-Georg Predel, et al.
Basic Research in Cardiology|April 13, 2011
Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutaseDerya Sivritas, Marc Ulrich Becher, Talin Ebrahimian, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 10, 2019
Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyIvana Hollan, Nicoletta Ronda, Patrick Dessein, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 13, 2019
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trialsHeinz Drexel, Giuseppe M C Rosano, Basil S Lewis, et al.
Basic Research in Cardiology|January 26, 2020
Murine sca1/flk1-positive cells are not endothelial progenitor cells, but B2 lymphocytesEva Steffen, Wolfgang Bernd Edziu Mayer von Wittgenstein, Marie Hennig, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2006
NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- miceMatthias Oelze, Ascan Warnholtz, Jörg Faulhaber, et al.
European Heart Journal|August 30, 2025
Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)Sigrid Sandner, Mario Gaudino, Stefan Agewall, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 30, 2025
Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)Sigrid Sandner, Mario Gaudino, Stefan Agewall, et al.
Pageof 8